Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2005
08/31/2005CN1660811A Compound of 1, 4-substituted benzenes and preparing method and application
08/31/2005CN1660810A Compound of monoimine pyridine, preparation method and catalyst containing the compound and application
08/31/2005CN1660754A Ramification biphenyl dienones and application
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216868C Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compunds
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/31/2005CN1216865C Method for preparing 2-phenyl-3-aminopyridine, and the substituled phenyl derivatives and salts thereof
08/31/2005CN1216858C Carbamate compound and its prepn.
08/30/2005US6936736 Vision defects; Parkinson's disease; Alzheimer's disease
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936611 Serine protease inhibitors
08/30/2005US6936610 Heterocyclic derivatives
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936186 Mesomorphic compound, polymeric mesomorphic compound, and electrolyte and secondary battery including same
08/25/2005WO2005077947A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
08/25/2005WO2005077902A2 Methods for the synthesis of pyridoxamine
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005US20050187375 Polymers and oligomers, their synthesis, and electronic devices incorporating same
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187264 2-Cyano-N-[4-(methoxymethoxy)phenethyl]-3-(3-pyridyl)-2-propenamide: generic derivatives described in WO 99/05109; asthma; bronchitis; rhinitis; vision defects; antiarthritic agents; antiallergens; sepsis; inflammatory bowel disease; bipolar disordes; schizophrenia; Crohn's disease; degenerative joints
08/25/2005US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine
08/25/2005US20050187251 Substituted N-heterocycle derivatives and methods of their use
08/25/2005US20050186635 Self-assembled monolayer comprising ferrocene for use in monitoring redox potentials in biological fluids
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/25/2005DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I
08/25/2005CA2556084A1 1,2,4-triazolo[4,3-a]pyridines useful in the treatment of gastrointestinal disorders
08/25/2005CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/24/2005EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565443A2 Acetyl 2-hydroxy-1,3 diaminoalkanes
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565441A2 Process for the preparation of 2-aminomethylpyridine derivative
08/24/2005EP1565440A1 Novel process for the preparation of 2-aminomethylpyridine derivative
08/24/2005EP1565439A1 Process for the preparation of vinylpyridine from picoline over modified zeolites
08/24/2005EP1565433A2 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
08/24/2005EP1565431A1 Cannabinoid receptor ligands
08/24/2005EP1565429A2 Aryl ureido derivatives and their medical use
08/24/2005EP1565428A1 Substituted ureas and carbamates
08/24/2005EP1565190A2 Arylcyclopropylcarboxylic amides as potassium channel openers
08/24/2005EP1565185A2 Neuroprotective iron chelators and pharmaceutical compositions comprising them
08/24/2005EP1409459A4 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659268A Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
08/24/2005CN1659239A Yellow anionic disazo dyes
08/24/2005CN1659238A Anthraquinone-azo dyes
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659142A Pyridine compounds or salts thereof and herbicides containing the same
08/24/2005CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
08/24/2005CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
08/24/2005CN1658871A Amide derivatives as GK activators
08/24/2005CN1658855A O-substituted hydroxyaryl derivatives
08/24/2005CN1658834A Method of treating mucus hypersecretion
08/24/2005CN1658724A Luminescent element material and luminescent element comprising the same
08/24/2005CN1216079C Polymersation catalysts
08/24/2005CN1216045C Process and catalyst for preparation of acetylpyridines
08/24/2005CN1215835C Ketone derivatives and medical use thereof
08/23/2005US6933412 Low loss high refractive index vinyl sulfide compounds and method of making same
08/23/2005US6933322 Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
08/23/2005US6933307 Fungicidal phenylimine derivatives
08/23/2005US6933305 Amide compounds and use thereof
08/23/2005US6933304 Antitumor agents, osteoporosis
08/23/2005US6933298 Matrix metalloproteinase inhibitor; osteoporosis, antiarthritic agents, rheumatic diseases
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/23/2005US6932960 Complexes with radionuclides; for use as contrast agent in magnetic resonance imaging (MRI); as parasiticide, viricide, or as chelation therapy of iron overload such as thalassemia; optimal combination of lipophilicity and hydrophilicity
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/23/2005CA2089442C Amino-substituted benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them
08/18/2005WO2005075601A1 Electroluminescent platinum compounds and devices made with such compounds
08/18/2005WO2005075597A2 Electroluminescent iridium compounds with fluorinated phenylpyridine ligands, and devices made with such compounds
08/18/2005WO2005075464A1 Pyridine derivatives as connabinoid receptor modulators
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005WO2005075425A2 Substituted bisarylurea derivatives as kinase inhibitors
08/18/2005WO2005075418A2 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
08/18/2005WO2005074919A1 Diurea derivatives
08/18/2005US20050182247 A diazotized dye from an anthraquinone compound; reactive dyes by coloring a high molecular weight plastics or polymeric particles; color filters in liquid crystal displays; colorfastness; chemical intermediates
08/18/2005US20050182120 Fungicides, microbiocides
08/18/2005US20050182103 Substituted 2,3-diphenyl pyridines
08/18/2005US20050182102 Pyridines and uses thereof
08/18/2005US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
08/18/2005US20050182096 Haloalkyl containing compounds as cysteine protease inhibitors
08/18/2005US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
08/18/2005US20050182078 inhibitors of cyclin-dependent kinases 2 and 4 (CDK2 and CDK4); antiproliferative agents; cancer, endometriosis, postsurgical vascular stenosis and restenosis
08/18/2005US20050182072 Paget's disease; muscular disorders; cardiovascular disorders; antiinflamamtory agents; antidiabetic agents; autoimmune disease; leukemia
08/18/2005US20050182068 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
08/18/2005US20050182060 2-Substituted and 4-substituted aryl nitrone compounds
08/18/2005US20050182040 Benzamide derivatives
08/18/2005US20050181948 For controlling phytopathogenic harmful fungi, mildew; (2Z)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methyl-2-[5-(trifluoromethyl)-2-pyridinyl]-2-pentenamide
08/18/2005US20050181393 Novel chelating agents and highly luminescent and stable chelates and their use
08/18/2005DE102004004731A1 Harnstoffderivate Urea derivatives
08/18/2005CA2555453A1 Cross-coupling process for production of aromatic compounds from aliphatic organic compounds and aromatic organometallic reagents
08/18/2005CA2555058A1 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
08/18/2005CA2554878A1 Bisarylurea derivatives
08/18/2005CA2551566A1 Diurea derivatives
1 ... 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 ... 633